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Abstract
Background: Stable isotope tracing is a powerful technique for following the fate of individual atoms through
metabolic pathways. Measuring isotopic enrichment in metabolites provides quantitative insights into the
biosynthetic network and enables flux analysis as a function of external perturbations. NMR and mass spectrometry
are the techniques of choice for global profiling of stable isotope labeling patterns in cellular metabolites.
However, meaningful biochemical interpretation of the labeling data requires both quantitative analysis and
complex modeling. Here, we demonstrate a novel approach that involved acquiring and modeling the timecourses
of
13C isotopologue data for UDP-N-acetyl-D-glucosamine (UDP-GlcNAc) synthesized from [U-
13C]-glucose in
human prostate cancer LnCaP-LN3 cells. UDP-GlcNAc is an activated building block for protein glycosylation, which
is an important regulatory mechanism in the development of many prominent human diseases including cancer
and diabetes.
Results: We utilized a stable isotope resolved metabolomics (SIRM) approach to determine the timecourse of
13C
incorporation from [U-
13C]-glucose into UDP-GlcNAc in LnCaP-LN3 cells.
13C Positional isotopomers and
isotopologues of UDP-GlcNAc were determined by high resolution NMR and Fourier transform-ion cyclotron
resonance-mass spectrometry. A novel simulated annealing/genetic algorithm, called ‘Genetic Algorithm for
Isotopologues in Metabolic Systems’ (GAIMS) was developed to find the optimal solutions to a set of simultaneous
equations that represent the isotopologue compositions, which is a mixture of isotopomer species. The best model
was selected based on information theory. The output comprises the timecourse of the individual labeled species,
which was deconvoluted into labeled metabolic units, namely glucose, ribose, acetyl and uracil. The performance
of the algorithm was demonstrated by validating the computed fractional
13C enrichment in these subunits against
experimental data. The reproducibility and robustness of the deconvolution were verified by replicate experiments,
extensive statistical analyses, and cross-validation against NMR data.
Conclusions: This computational approach revealed the relative fluxes through the different biosynthetic pathways
of UDP-GlcNAc, which comprises simultaneous sequential and parallel reactions, providing new insight into the
regulation of UDP-GlcNAc levels and O-linked protein glycosylation. This is the first such analysis of UDP-GlcNAc
dynamics, and the approach is generally applicable to other complex metabolites comprising distinct metabolic
subunits, where sufficient numbers of isotopologues can be unambiguously resolved and accurately measured.
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Stable isotope tracing is a powerful technique for deli-
neating metabolic pathways and fluxes in response to
external perturbations in a wide variety of systems [1-4].
We have been developing stable isotope-resolved meta-
bolomic analysis (SIRM) for polar and non-polar meta-
bolites in cell and tissue systems to obtain a
comprehensive view of the flow of carbon or nitrogen
through different metabolic pathways [5-12].
This approach involves the combined use of NMR and
mass spectrometry (MS), both at very high resolution,
which respectively provide direct information on posi-
tional isotopomers and isotopologues (sometimes
termed ‘mass isotopomers’) of labeled metabolites in an
unfractionated mixture, thereby minimizing errors from
sample processing [10]. NMR and MS are complemen-
tary structural techniques; both types of analytical infor-
mation are crucial for accurate reconstruction of
metabolic pathways leading to the synthesis of labeled
metabolites [8,13]. For complex metabolites that are
composed of several metabolic subunits such as UDP-
N- a c e t y l - D - g l u c o s a m i n e( U D P - G l c N A c ;s e eF i g u r e1 ) ,
the observed isotopologues are mixtures of several posi-
tional isotopomers even at the level of the individual
metabolic subunits. This degeneracy makes pathway
reconstruction and metabolic flux modeling extremely
complex. To solve this problem we have developed a
technique for deconvoluting
13C isotopologues into all
possible labeled subunits with
13C distribution in the
subunits mapped based on knowledge of their biosyn-
thetic pathways. This approach is illustrated here with
the metabolite UDP-GlcNAc, which is composed of four
metabolic modules, namely uracil (U), ribose (R), glu-
cose (G) and acetyl (A) (Figure 1). The technique can be
applied to any complex metabolite where a sufficient
number of mass isotopologues can be identified and
accurately quantified.
UDP-GlcNAc is an activated precursor for both N-
linked and O-linked glycosylation of proteins, which are
important in regulating numerous cellular processes,
such as protein targeting to organelles [14] and nutrient
sensing [15,16]. These two major glycosylation pathways
in eukaryotic cells differ in the protein targets and cellu-
lar localization [17]. With O-linked glycosylation, cyto-
plasmic and nuclear proteins are modified by the
transfer of a single b-N-acetylglucosamine (GlcNAc)
unit from UDP-GlcNAc to the oxygen of Ser or Thr
side chains of proteins. This reaction is catalyzed by the
enzyme uridine diphospho-N-acetylglucosamine:poly-
peptide b-N-acetylglucosaminyltransferase (O-GlcNAc
transferase, or OGT). O-Linked GlcNAcylation has been
shown to participate in a variety of cytoplasmic and
nuclear regulatory processes in response to stress in a
fashion both similar and complementary to phosphory-
lation [15,18-20]. O-GlcNAc modified proteins including
the polycomb group, p53, c-Myc, insulin receptor have
Figure 1 Biosynthesis of UDP-N-acetyl-D-glucosamine (UDP-GlcNAc). The pathways from [U-
13C]-glucose to the four biochemical subunits
are outlined. The glucose moiety (red) is directly incorporated into UDP-GlcNAc. The acetyl moiety (blue) is incorporated via glycolysis. The
ribose moiety (yellow) is incorporated via the pentose phosphate pathway and pyrimidine biosynthesis. The uracil moiety is derived from acetyl-
CoA through the Krebs cycle to form aspartate where it is combined with carbamoyl phosphate leading to pyrimidine synthesis (green).
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[21], cancer [22,23] and diabetes [24]. In addition, the
synthesis and turnover of these modified proteins are
tightly regulated, which implies that the supply of the
precursor UDP-GlcNAc must also be tightly regulated.
Using ultra-high-resolution and accurate mass Fourier
transform-ion cyclotron resonance-MS (FT-ICR-MS)
and high-resolution NMR, we have identified four major
sugar nucleotides including UDP-Glc and UDP-GlcNAc
directly in crude extracts of mammalian cells. The bio-
synthesis of UDP-GlcNAc is complex as it involves the
interplay of both sequential and parallel metabolic path-
ways (see Figure 1). Thus, one must simultaneously con-
sider glycolysis, the hexosamine biosynthetic pathway
(HBP), the Krebs cycle, the pentose phosphate pathway,
and the pyrimidine biosynthetic pathway when investi-
gating UDP-GlcNAc metabolism. Fortunately, isotopo-
mer distributions in several key metabolites (’reporters’)
of these pathways, including lactate, glucose, UDP-
GlcNAc, and uridine, can be readily identified and quan-
tified by NMR [10,25]. For abundant or sufficiently
enriched metabolites, NMR is also excellently suited for
following the time evolution of positional isotopomers
in cell culture and in vivo ([4,26-28], and see below).
For less abundant metabolites and where isotopic steady
state is difficult to achieve, such as in mammalian cell
cultures, the more sensitive FT-ICR-MS technique is
advantageous. However, mass spectrometry measures
isotopologues, which must be deconvoluted into indivi-
dual isotopomer species for dynamic flux analysis.
For flux analysis, detailed times courses are also
needed for systems that are not in isotopic steady state.
Numerous modeling techniques, including metabolic
balance analysis [29-31], metabolic control analysis
[31-33] have been developed which use a series of differ-
ential equations to model the flux of metabolites. These
techniques typically require steady-state conditions that
apply standard numerical methods to solve a system of
differential equations in the form of an eigensystem,
though there are a few techniques that can be applied
to non-steady-state conditions [34,35]. While steady-
state conditions are often assumed, in reality they are
difficult to establish, maintain, and verify for all relevant
metabolites in experiments involving mammalian cells.
Most of these modeling techniques rely on total meta-
bolite concentrations or isotopic enrichment ratios of a
limited number of metabolites, which creates an under-
determined system of equations where there are more
variables than independent data. Thus, unique meaning-
ful solutions to these numerical systems are not always
practical [36].
H e r e ,w eh a v eu s e db o t hN M Ra n dF T - I C R - M St o
probe the biosynthesis of UDP-GlcNAc in prostate can-
cer cells, coupled with the development of algorithms to
deconvolute the resulting MS data. LnCaP-LN3 prostate
c a n c e rc e l l sw e r eg r o w ni n[ U -
13C]-glucose to trace the
time-dependent fate of individual
13C atoms in different
metabolic subunits of UDP-GlcNAc. The
13C isotopolo-
gue distribution in UDP-GlcNAc was measured by
direct infusion nanoelectrospray FT-ICR-MS. As we
have previously shown, the resolution in the MS is suffi-
cient to resolve all 17
13Ci s o t o p o l o g u e so fU D P -
GlcNAc (Figure 2) from other metabolites and other
elemental isotopologues (for example,
2H,
15N,
18O, and
all possible combinations of isotopes) of UDP-GlcNAc
plus providing intensity measurements with an accuracy
and precision of better than 1% [5]. The MS data was
then deconvoluted and modeled using the newly devel-
oped algorithm. This combined analytical and computa-
tional approach generated much more independent
isotopomer data to help minimize the problem under
determination. To the best of our knowledge, this is the
first detailed kinetic analysis of the UDP-GlcNAc path-
ways by stable isotope analysis.
Results
Metabolism of LN3 cells
As with many other cancer cells in culture,
13Cg l u c o s e
is a major source of carbon for nucleotide riboses (via
the pentose phosphate pathways), amino acids such as
Ala, Glu and Asp via glycolysis and the Krebs cycle, and
pyrimidine rings in LnCaP-LN3 cells. These metabolites
are in turn precursors of glutathione, proteins, pyrimi-
dine nucleotides and sugar nucleotides. The unlabeled
and labeled metabolite profiles of the LN3 cells and
m e d i ag r o w ni nt h ep r e s e n c eo f[ U -
13C]-glucose were
determined by NMR and mass spectrometry as
described in the Methods section. We have determined
the relative rates of consumption of glucose, glutamine
and essential amino acid, and lactate production in the
medium by NMR (Additional file 1). As the number of
cells approximately doubled during the measurement
period, the determination of the rates of consumption
per unit of cells is complicated, and leads to inconstant
rates over time, as we have previously discussed [37].
The initial rates per mg dry weight are given in Addi-
tional file 1. Under the conditions used (initial 1.4 mil-
lion cells), the rate of glutamine consumption was
sevenfold slower than the glucose uptake rate. From the
rate of
13C lactate excretion, we calculated that about
38% of the consumed glucose was converted to lactate
and excreted, which is comparable to other cancer cells
in culture [9,38]. Furthermore, around 30% of the glu-
cose was consumed by 48 h (Additional file 1). Many
other intracellular metabolites and their
13C isotopomers
that report on central metabolic pathways were identi-
fied and quantified. These included the intracellular lac-
tate and Ala, Glu, Asp and uracil (that report on
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the ribose components of the free nucleotide pools that
reflect the pentose phosphate pathway (Figures 3 and 4
and Table 1). We also identified four sugar nucleotides
(Figure 5a), which are associated with these carbon
flows (see Figure 1).
Identification of sugar nucleotides
Figure 5a shows a partial
1H NMR spectrum that corre-
sponds to the sugar nucleotide region. The resonance at
5.51 ppm shows the characteristic quartet pattern of the
anomeric proton of a pyranose sugar unit in a nucleo-
tide as a result of the three-bond coupling to H2 and
A
B
Figure 2 Species assignments of UDP-N-acetyl-D-glucosamine (UDP-GlcNAc) isotopologues in Fourier transform-ion cyclotron
resonance-mass spectrometry (FT-ICR-MS). The same crude extracts used for NMR were analyzed following re-exchange of
2H back to
1H.
Analysis conditions are stated in the text. With correction to an internal reference, all of the isotopologues were assignable at better than 1 ppm
mass accuracy, with most better than 10 ppb mass accuracy. The molecular formulae were assigned using Xcalibur software with elemental
limits set to CHONP and allowing up to 17 occurrences of
13C. The combination of the ultra-high resolution with extreme mass accuracy
resulted in high confidence that only ‘pure’
13C isotopologues were quantified for the moiety modeling.
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1H total correlation spectro-
scopy (TOCSY) spectrum (Figure 5b) shows the
expected pattern of
13C satellite crosspeaks for the glu-
cosyl moiety of sugar nucleotides. Comparing the che-
mical shifts and scalar coupling patterns with those of
authentic standards, we assigned these resonances to
four different nucleotide sugars, namely UDP-Glc, UDP-
GlcNAc, UDP-Gal and UDP-GalNAc. These were con-
sistent with the molecular formula obtained from the
ultra-high-mass resolution FT-ICR-MS (see below).
Isotopomer distributions of metabolites determined by
NMR
UDP-GlcNAc is composed of four metabolic units or
modules, each of which is synthesized in different path-
ways (see Figure 1). The glucose unit derives directly
from the supplied glucose without metabolic scrambling,
as these cells are not known to be gluconeogenic. Simi-
larly, the ribose can also be derived from the supplied
glucose, or from the turnover of existing ribonucleo-
tides. The uracil unit may be derived from RNA turn-
over, or de novo synthesis, which requires carbon input
from aspartate and CO2. Aspartate can be produced by
protein turnover or transamination of oxalacetate
(OAA) (Figure 1). OAA can incorporate carbon from
acetyl CoA, which is derived from glucose, or from glu-
tamine carbon entering the Krebs cycle via glutaminoly-
sis [4,38]. The acetyl moiety is derived either from
glycolysis or fatty acid oxidation. The glucose pathways
were readily discriminated from the non-glucose path-
ways by tracing the
13C label from [U-
13C]-glucose into
the various biosynthetic intermediates, as well as in
UDP-GlcNAc itself (see Table 1).
After introduction of [U-
13C]-glucose enriched medium,
the free intracellular glucose was rapidly replaced by [U-
13C]-glucose, and the metabolically proximal metabolites,
such as the ribose rings of the free nucleotides also
became highly labeled. The glycolysis markers, Ala and
lactate were preferentially labeled from the glucose source,
and the glucose unit within UDP-GlcNAc became > 90%
enriched in
13C by 48 h. Based on the NMR data, these
markers were either the all
13C, or the all
12C form, after
correcting for natural abundance
13C at approximately
1.1%) (Figures 3, 4a and 5b; Table 1). In contrast, the
downstream metabolites that report on both glycolysis
and Krebs cycle activity (Asp, Glu) were considerably less
13C labeled, and also showed scrambling due to reactions
with unlabeled intermediates in the Krebs cycle (for exam-
ple, citrate synthase, 2-oxoglutarate dehydrogenase steps)
(Figures 3 and 4b). A significant source of unlabeled Krebs
cycle intermediates is glutamine (see above). As Asp is a
direct precursor of uracil biosynthesis, we expected the
final product would also show scrambled labeling patterns;
the labeling pattern in Asp was essentially identical to that
of U in UXP, as expected for a direct precursor-product
relationship (see Table 1).
Isotopologues of UDP-GlcNAc determined by FT-ICR-MS
The 17 possible
13C isotopologues of UDP-GlcNAc in
LN3 cell extracts were analyzed using direct infusion
nanoelectrospray FT-ICR-MS, which is especially well
suited for mass isotopologue analysis. FT-ICR-MS
requires no derivatization, the relative intensities are sig-
nificantly more accurate than conventional MS, routine
mass accuracy is better than 0.5 ppm, and the analysis is
relatively high-throughput. Most importantly, the extre-
mely high mass resolution makes interference from
other metabolites and non-
13Ci s o t o p o l o g u e sh i g h l y
unlikely [5]. Moreover, the high sensitivity and small
sample requirements (low to sub-pmol levels of UDP-
GlcNAc) make the technique well suited for timecourse
measurements. The spectral assignments of the UDP-
GlcNAc isotopologues in LN3 extracts are shown in Fig-
ure 6a, along with timecourse changes at 6, 34 and 48 h
post labeling. The isotopologue peaks of UDP-GlcNAc
are tagged as m0 to m0+16, which represent the monoi-
sotopic (all
12C) to
13C16 species. The detailed time-
courses of various isotopologue intensities are shown in
Figure 6b, which display a typical precursor product
relationship. Some isotopologues (that is, m0+3-4, m0
+7-10) were not sufficiently enriched to determine the
timecourse, and thus were not plotted. The m0 peak dis-
appeared rapidly with a half life of 5.3 h (Figure 6b),
Figure 3 13C Labeling in metabolites that report on glycolysis,
Krebs cycle and uracil biosynthesis. The two-dimensional
1H total
correlation spectroscopy (TOCSY) spectrum was recorded at 18.8 T
using an isotropic mixing time of 50 ms at a B1 field strength of 8
kHz. The
13C satellites of glutamate and glutamate in reduced
glutathione C2H-C4H are shown in cyan. This pattern corresponds
to a mixture of species, namely where both
13C atoms are labeled
in the same molecule plus
13C2
12C4 and
12C2
13C4. In contrast, the
patterns for Ala (red) and Lac (green) shows only the
13C3
13C2 plus
12C3
12C2 pattern. Aspartate (red) shows a similar pattern as
glutamate, reflecting scrambling through the Krebs cycle [8,10,11],
and is the same as in U in UTP.
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UDP-GlcNAc by newly synthesized
13Ci s o t o p o l o g u e s .
At zero time the fraction of the m0 peak was about 85%,
close to the expected 83% from natural abundance. In
contrast, the intensity of other isotopologues increased
with time, and some took more than 1 d to become sig-
nificantly labeled.
Isotopologue analysis
Starting with
13C glucose, the complete synthesis of
UDP-GlcNAc leads to a total of 17 isotopologues (see
below), many of which comprise several isotopomers.
However, as each isotopologue was independently
quantified and the intensity profile contained more
measurements than the number of independent isoto-
pomer species, the observed profile can be deconvo-
luted into the individual isotopomer components in
terms of biochemical units. The intensity at a given
mass is the sum of the intensities of the individual iso-
topic species at that mass, and the net intensity due to
13C enrichment was corrected for natural abundance
13C contribution using the previously described strip-
ping algorithm [39].
Algorithm
UDP-GlcNAc comprises four biochemical units: glu-
cose (G), ribose (R), acetyl (A) and uracil (U); g0, r0,
a0 and u0 represent the probability of finding
A
B
Figure 4 Two-dimensional
1H total correlation spectroscopy (TOCSY) spectra of components of UDP-N-acetyl-D-glucosamine (UDP-
GlcNAc). (a) Ribose ring region of the TOCSY spectrum (see Figure 3). The ribose moieties of the free nucleotides are essentially completely
labeled by 48 h. Adenine nucleotides AXP H1’-H2’ (red); uracil nucleotides UXP H1’-H2’ (purple). (b) Uracil ring in UXP shows the scrambled
pattern in the C5-C6 positions of U as in the precursor aspartate residue (Figure 3).
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tively. The NMR data (Figures 2b and 4b) showed that
the glucose and ribose units existed significantly only
as fully
13C-labeled G6 and R5, or completely unla-
beled (G0, R0) forms, after 24 and 48 h of labeling.
Furthermore, the mass isotopologue timecourse (Figure
6a) showed absence of m0 to m4 intensity, which is
consistent with these subunits being enriched with all
13C or none. However, it was unclear from the NMR
data whether the possibility of isotopic mixing existed
for the acetyl unit, which was specifically considered in
t h em o d e l i n g( s e eb e l o w ) .
If g0 represents the mole fraction of
12C6 glucose, G0,
it follows that:
g6 = 1 − g0 (1a)
and similarly for the ribose and acetyl units,
r 5=1− r0; a2 = 1 − a0 (1b)
The biosynthesis of uracil mixes carbon from glucose
and other sources such as glutamine through the
Krebs cycle. This leads to several isotopologues,
namely u0, u1, u2 and u3 where the indices 1, 2 and 3
refer to the number of
13C atoms in the ring, which
can be measured by NMR (see below). Moreover, these
probabilities sum to unity:
u 0+u 1+u 2+u 3=1 (2)
Hence, there are 6 undetermined parameters to be
calculated, and up to 32 possible isotopomers. However,
at each timepoint there are 17 intensity measurements.
If In denotes the intensity of the nth isotopologue, then
using Eq. 1 and 2:
I0 = g0r0a0u0
I1 = g0r0a0u1
I2 = g0r0a0u2 + g0r0a2u0
I3 = g0r0a0u3 + g0r0a2u1
I4 = g0r0a2u2
I5 = g0r5a0u0 + g0r0a2u3
I6 = g6r0a0u0 + g0r5a0u1
I7 = g6r0a0u1 + g0r5a2u0 + g0r5a0u2
I8 = g6r0a2u0 + g6r0a0u2 + g0r5a0u3 + g0r5a2u1
I9 = g6r0a0u3 + g6r0a2u1 + g0r5a2u2
I10 = g6r0a2u2 + g0r5a2u3
I11 = g6r5a0u0 + g6r0a2u3
I12 = g6r5a0u1
I13 = g6r5a0u2 + g6r5a2u0
I14 = g6r5a0u3 + g6r5a2u1
I15 = g6r5a2u2
I16 = g6r5a2u3
I17 = Natural abundance contribution only
(3)
To solve these simultaneous equations (Eq. #3), we
have developed a general simulated annealing/genetic
algorithm for parameter optimization called Genetic
Table 1 Quantification of
13C enrichments in relevant
metabolites by
1H total correlation spectroscopy (TOCSY)
at 48 h
Compound Percentage
13C
Uracil in UXP
12C6
12C5 52 ± 3
12C6
13C5 14 ± 2
13C6
12C5 16 ± 2
13C6
13C5 18 ± 2
Asp
12C2
12C3 46 ± 3
12C2
13C3 15 ± 2
13C2
12C3 19 ± 2
13C2
13C3 21 ± 2
AXP ribose
12C1’
12C2’ 8±2
13C1’
13C2’ 92 ± 2
UXP ribose
12C1’
12C2’ 4±1
13C1’
13C2’ 96 ± 2
UDP GlcNAc
Glc
12C1
12C2 9 ± 2
Glc
13C1
13C2 91 ± 2
Lactate
12C2
12C3 19 ± 2
13C2
13C3 81 ± 2
Alanine
12C2
12C3 23 ± 2
13C2
13C3 77 ± 2
Glutamate
12C2
12C4 63 ± 2
12C2
13C4 32 ± 2
13C2
12C4 < 1
13C2
13C4 5 ± 2
12C2
12C3 81 ± 2
12C2
13C3 6 ± 2
13C2
12C3 5 ± 2
13C2
13C3 8 ± 2
Atom percentage
13C enrichments in metabolites after 48 h incubation in [U-
13C]-glucose were determined from two-dimensional
1H TOCSY experiments
as described in the Methods section. Uracil in UXP refers to the uracil ring in
the free nucleotide pool comprising UTP, UDP and UMP. AXP and UXP ribose
refer to the ribose moiety in the free nucleotide pools. UDP-N-acetyl-D-
glucosamine (UDP-GlcNAc) refers to the C1-C2 of the glucose moiety of the
free UDP-GlcNAc pool.
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Figure 5 NMR identification of UDP-hexoses. LN3 cells were grown in unlabeled glucose and extracted as described in the Methods section.
One-dimensional
1H NMR spectra were recorded at 20°C, 800 MHz. Two-dimensional
1H total correlation spectroscopy (TOCSY) spectra were
recorded at 600 MHz using a mixing time of 50 ms with a spin lock field strength of 8 kHz. (a) One-dimensional NMR spectrum. The sugar
anomeric region shows several resonances that are double doublets, that is, a single proton scalar coupled to two different spin 1/2 nuclei. By
comparison with standard spectra, these have been assigned to the glucose H1 of UDP-glucose, UDP-galactose (UDP-Gal), UDP-GalNAc and
UDP-GlcNAc by
1H and
13C chemical shifts, splitting patterns,
13C labeling and two-dimensional TOCSY crosspeak patterns as described in the
text. (b) Anomeric region of example TOCSY spectrum showing
13C satellites of glucose H1-H3 of UDP-GlcNAc due to incorporation of [U-
13C]-
glucose. The satellite crosspeaks (denoted by red rectangles) represent the covalent linkages of H1 to H2 and H3 of the glucose moiety (labeled
respectively as G1, G2 and G3), which were essentially completely labeled at 48 h. Crosses denote the crosspeaks of protons attached to
12C.
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Figure 6 Timecourse changes of UDP-N-acetyl-D-glucosamine (UDP-GlcNAc) isotopologues in LN3 extracts as determined by Fourier
transform-ion cyclotron resonance-mass spectrometry (FT-ICR-MS). (a) FT-ICR-MS spectra at 6, 34 and 48 h post [U-
13C]-glucose labeling.
The spectra are plotted by normalization to cellular concentrations for direct comparison. For clarity, only the isotopologues visible at this scale
are tagged; it should be noted that by 34 h the monoisotopic UDP-GlcNAc (m0) was barely detectable (data not shown). As is evident from this
figure, different isotopologues increased in intensity at different rates, resulting in changing isotopologue distributions. M0+5, 7-16 correspond to
the UDP-GlcNAc isotopologues with 5 and 7 to 16
13C atoms, respectively. (b) Timecourses of intensity of selected mass isotopologues. The
normalized intensities were obtained as described in the Methods section. Only mass isotopologues that reached a significant level are plotted.
Symbols are defined in the figure. The lines only serve to connect the data points. M0, 5,6, 11-16 represent monoisotopic UDP-GlcNAc and
isotopologues with 5, 6 and 11 to 16
13C atoms, respectively.
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(GAIMS) [40], (available at http://bioinformatics.chem.
louisville.edu/). This algorithm robustly finds the opti-
mal solution for all intensities via fitting of these six
independent parameters (that is, g0, r0, a0, u0, u1, and
u2). The target function, T, which is minimized, is
defined in Eq. (4) as:
T=|(In,obs − In,calc)| (4)
where, In,obs and In,calc are the observed and calculated
intensities, respectively, at a given timepoint. This opti-
mization method used a linear annealing regime along
with a 5% crossover rate and a population size of 20.
Furthermore, three variables were mutated per step to
handle any issues of dependency between variables.
Each optimization used 10
6 steps and was repeated 50
times to verify robustness (avoidance of local minima)
and to provide statistics. In addition, GAIMS was
applied to over 40 variant models that include the possi-
bility of other isotopomers in the various subunits (see
Additional file 1) and a robust model selection method
using the Akaike information criterion (AIC) [41], which
was applied to average optimized parameter values.
Testing and implementation
The mole fractions of individual isotopomers were cal-
culated from the isotopologue intensity distributions in
Figure 6b using the six-parameter optimizations from
the GAIMS algorithm as described in the Methods sec-
tion. In addition, we used the Akaike information cri-
teria (AIC)-based model selection method described in
the Methods section to select among 40 variant models
(see Additional file 1). The best model according to
these criteria, which also made the most biological
sense, was our original six-parameter model. Specifically,
allowing for all isotopomers of the acetyl unit produced
significantly worse AIC values [40], justifying our origi-
n a la p p r o x i m a t i o no na l lo rn o n e
13C labeling in the
acetyl unit post hoc.
Figure 7a shows the mole fraction of the deconvoluted
isotopomer components (see the Methods section) as a
function of time. The standard deviations were calcu-
lated from 50 independent optimizations, and were rela-
tively small for most species except for the acetyl unit,
which appeared to be less well determined. As Figure 7a
indicates, the
13C enrichment into the ribose component
was rapid (half life of approximately 6 h) and reached a
plateau value of about 90%, similar to that measured by
N M R( T a b l e1 ) .T h er a t eo f
13C incorporation into the
ribose component was similar to the rate of decrease in
the unlabeled UDP-GlcNAc (Figure 7a), consistent with
a direct precursor-product relationship. Interestingly,
the enrichment into the glucose component showed a
distinct lag of around 10 h, after which the enrichment
reached a plateau value of > 90%, as evident also by
NMR at 48 h. Furthermore, as the uracil and acetyl
components require many more transformation steps,
the enrichment into these species should take more
time, as was observed (see Figure 7a).
The reconstruction of the isotopologue distribution
from GAIMS modeling was compared with the observed
values, as shown in Figure 7b for the 48 h timepoint.
The agreement was as good as the variance in the data,
and further modeling that included more species (such
as
13C1 acetate) gave no improvement of the fitting,
according to a variety of criteria (see the Methods sec-
tion). Thus, based on the model calculation, the fraction
of the uniformly
13C-labeled glucose, ribose, acetyl units
in UDP-GlcNAc were respectively 0.84, 0.93, and 0.3,
while the fraction of singly, doubly, and triply
13C-
labeled uracil units was respectively 0.18, 0.46, and 0.14
at 48 h. These compare favorably with the independent
isotopomer analysis by NMR at 48 h of incubation (see
Table 1).
Discussion
We have unequivocally identified four UDP-hexoses in
LN3 cells using a combination of NMR and FT-ICR-MS
data. In these cells, the most abundant sugar nucleotide
was UDP-GlcNAc (Figure 1), whereas in other cancer or
normal cells (for example, A549, MDAMB231, NHBE),
UDP-Glc is the major sugar nucleotide (TW-M Fan and
AN Lane, unpublished data). The abundance of UDP-
GlcNAc in LN3 cells could mean a high synthesis rate,
which could in turn drive a high OGT activity [42,43].
As Figure 1 shows, the biosynthesis of UDP-GlcNAc is
complex, involving the coordination of glycolysis, Krebs
cycle, pentose phosphate pathway, pyrimidine biosynth-
esis, and hexosamine biosynthesis. The total concentra-
tion of UDP-GlcNAc (and the other nucleotide hexoses)
was maintained constant in LN3 cells over the time-
course, that is, at a steady state in which utilization was
balanced by de novo synthesis. However, the
13Ci n c o r -
poration into the individual intermediates did not
approach isotopic steady state for at least 30 h (Figure
7a). Thus, non-steady-state approaches [34,35,44] are
required for the flux analysis.
The approach that we introduced here enabled a
quantitative analysis of fractional contribution of rele-
vant pathways to the synthesis of UDP-GlcNAc, regard-
less of whether the steady-state conditions are met. The
U D P - G l c N A cm o l e c u l ew a sdissected into four bio-
chemical modules, each of which can utilize glucose as
the carbon source. The exception is uracil, where one of
the carbons comes from bicarbonate. In addition to glu-
cose, alternative sources of carbon were also considered.
The hexose unit in LN3 cells should derive exclusively
Moseley et al. BMC Biology 2011, 9:37
http://www.biomedcentral.com/1741-7007/9/37
Page 10 of 151 
A 
B 
1
Figure 7 Deconvolution of isotopologues of UDP-N-acetyl-D-glucosamine (UDP-GlcNAc) and kinetic modeling of their timecourses.
Mass isotopologues at each timepoint were deconvoluted into individual isotopomer components and their intensity was corrected for natural
abundance contribution, as described in the Methods section. (a) Mole fractions of the various components are plotted with time. m0 (open
square),
13C6-glucose g6 (black filled square),
13C5-ribose r5 (open circle),
13C2-acetyl a2 (black filled circle),
13C1-uracil u1 (blue filled square),
13C2-
uracil u2 (green filled square),
13C3-uracil u3 (red filled square). The ribose component was fitted to the function b(1-exp-kt) with b = 0.89 and k
= 0.13 h
-1 R
2 = 0.977. The unlabeled species (m0) was fitted to a single exponential decay I(t) = I(0)exp(-kt) with I(0) = 0.88 ± 0.06, k = 0.13 ±
0.02 h
-1 R
2 = 0.967. (b) Reconstruction of the isotopologue distribution from the mole fraction probabilities in A for the 48 h timepoint. The best
fit values for the fractions were obtained according to equations 3,4 and 5 using the ‘Genetic Algorithm for Isotopologues in Metabolic Systems’
(GAIMS) as described in the text. The symbols are given on the figure. Blue bars are the observed intensities at each m/z and red bars are the
reconstructed intensities.
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13C]-glucose in the medium since
there was no evidence for active gluconeogenesis in
these cells. The ribose unit of the UTP pool was also
d e r i v e dm a i n l yf r o m[ U -
13C]-glucose. Acetyl CoA could
be made from pyruvate via glycolysis, by fatty acid oxi-
dation, or from glutaminolysis [45] by way of malic
enzyme. For uracil, the C4, C5 and C6 carbons were
derived from aspartate, which could be obtained from
protein degradation or by the transamination of OAA.
OAA could in turn come from [U-
13C]-glucose via the
Krebs cycle or amino acid oxidation, especially gluta-
mine, which is a more direct carbon source than glu-
cose. Our 6-parameter model based on the above
rationalization of
13C incorporation from [U-
13C]-glu-
cose was corroborated by its comparison and preferred
selection from over 40 variant models, representing
many alternate pathways discussed above.
The resulting modeled timecourses for the various
labeled intermediates (Figure 7a) are as expected for a
largely sequential series of reactions. The isotopologue
m0+5 represents the first labeled intermediate generated
in the complex pathways (see also Figure 6b). All other
significantly populated intermediates show clear lag
phases as expected for sequential reactions that are
effectively irreversible. It is notable that the length of
the lag period increased as the number of
13Ca t o m s
increased (Figure 7a), which reflects the increasing num-
ber of reactions needed to achieve the labeling.
The decay of the fraction of the m0 species (I0)w a s
quasi exponential (Figures 6b and 7a) and can be
regarded as the rate of UDP-GlcNAc utilization (for
example, incorporation into proteins). Since the total
concentration of UDP-GlcNAc was constant, a decrease
in the fraction of m0 was compensated by the synthesis
of UDP-GlcNAc (that is, those bearing at least one
13C
atom). The initial rate of formation of the m0+5 species
was essentially equal to the rate of loss of m0 (Figures
6b and 7a), which corresponds to two possible isotopo-
mer species (Equation 3). During the initial periods, the
most likely species would be
13C5-ribose (fully labeled
ribose, Figure 7a), as the acetyl CoA and uracil units
take longer to become labeled and did not reach such a
high degree of labeling (Figure 7a). Thereafter, the rapid
rise and disappearance of the m0+5 isotopologue in Fig-
ure 6b indicates that initially the glucose, uracil and
acetyl units of UDP-GlcNAc arose from pre-existing
unlabeled sources, and that these sources are depleted
relatively rapidly. Only then will de novo synthesis of
UDP-GlcNAc have an increasing contribution from
labeled glucose, uracil and acetyl CoA, leading to the
fractional decrease of the m0+5 isotopologue.
The present timecourse was acquired by discrete sam-
pling at separate timepoints, which could be done more
elegantly by continuous in vivo NMR measurement
[26,28]. However, UDP-GlcNAc is a relatively low abun-
dance metabolite, which was difficult to detect by NMR.
More importantly, the in vivo NMR analysis would lack
the necessary resolving power to quantify as many isoto-
pomer species of UDP-GlcNAc as required for the mod-
eling effort. The superior sensitivity and resolution of
the FT-ICR-MS techniques outweigh the in vivo NMR
advantage and enabled modeling of the flux through the
complex pathway, with much less ambiguity and under
non-isotopic steady-state conditions.
Conclusions
We have unequivocally identified four UDP-hexoses in
LN3 cells of which the most abundant was UDP-
GlcNAc using a combination of NMR and FT-ICR-MS
data. The
13C incorporation into the individual inter-
mediates did not approach isotopic steady state for at
least 30 h, thus requiring non-steady-state approaches
for flux analysis.
Our non-steady-state approach enabled a quantitative
analysis of fractional contribution of relevant pathways
to the synthesis of UDP-GlcNAc, by partitioning the
UDP-GlcNAc molecule into four biochemical modules
(glucose, ribose, uracil, and acetyl unit), each of which
can utilize glucose as the carbon source. Our analysis
indicated a rapid incorporation of labeled ribose via the
pentose phosphate pathway and direct glucose incor-
poration. Slower incorporation occurred for labeled
acetyl units and uracil via glycolysis and the Krebs cycle.
Such quantitative deconvolution of UDP-GlcNAc iso-
topologues into fractional contribution of individual
pathways (see Figure 7b) sets the stage for a detailed
flux analysis of UDP-GlcNAc biosynthesis and utiliza-
tion, which is work in progress. Since the FT-ICR-MS
and NMR data also provided labeling patterns of
numerous other metabolites in the nucleotide sugar
pathways, the flux analysis can be readily extended to
the network of other nucleotide sugars. Because modu-
lar biosynthetic processes occur commonly in cellular
metabolism (for example, phospholipid biosynthesis [5]),
the approach described should be of general
applicability.
Methods
Materials
Nucleotide standards were purchased from Sigma
Aldrich (St Louis, MO, USA) and used without further
purification. All other reagents were of the highest grade
commercially available.
Cell culture
The LnCaP-LN3 prostate cancer cell line was a gift of Dr
Clement Ip at the Roswell Park Cancer Institute (Buffalo,
NY, USA). Cells were grown in RPMI 1640 medium
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10% fetal bovine serum (FBS)(Atlanta Biologicals, Law-
renceville, GA), 100 units/ml penicillin, 100 μg/ml strep-
tomycin, and 0.2% glucose at 37°C and 5% CO2. For
timecourse experiments, cultures were grown to approxi-
mately 70% confluence before replacing medium (20 ml
per plate) with 0.2% [U-
13C] glucose (Sigma Isotec, St.
Louis, MO, USA) supplemented RPMI 1640. Initial cell
densities were 1.4 × 10
6 per plate. The doubling time of
the cells under these conditions was approximately 40 h.
For timecourse sampling, culture medium was collected
and frozen before cells were detached with 0.25% trypsin.
After 5-7 min of incubation, trypsin was inactivated with
fresh medium, and cells were collected by centrifugation
at 1,200 rpm (281 g) at 4°C for 5 min. The resulting pellet
was resuspended in ice-cold phosphate buffered saline
(PBS) for cell counting. Cells were then centrifuged and
resuspended again with ice-cold PBS before centrifuga-
tion at 4,000 rpm (1,700 g)a t4 ° Cf o r5m i n .T h es u p e r -
natant was removed and the wet cell mass was measured
before freezing in liquid N2 and subsequent lyophiliza-
tion. Cells were harvested in duplicates at 0, 3, 6, 11, 24,
34, and 48 h of [U-
13C] glucose incubation to generate a
timecourse of labeling of intracellular metabolites.
The corresponding medium samples were analyzed to
assess the consumption of glucose and excretion of lac-
tate derived from labeled glucose, as previously described
[9,11].
Polar metabolite extraction
Medium aliquots of 100 μl were extracted with 10% tri-
chloroacetic acid (TCA) and centrifuged at 14,000 rpm
for 20 min at 4°C to remove denatured proteins. Super-
natant was collected and lyophilized for NMR analysis.
The dried medium extract was dissolved in 650 μlD 2O
+ 50 nmol 2,2-dimethyl-2-silapentane-5-sulfonic acid-d6
(DSS-d6) (Sigma Isotec, St. Louis, MO) and transferred
to a 5 mm NMR tube. The DSS-d6 was used as a stan-
dard both for chemical shift and concentration. Dried
cell samples were homogenized in 60% CH3CN at a
40:1 CH3CN:mg dry cell mass ratio and incubated at
-80°C for 30 min to promote precipitation of denatured
proteins. Samples were then thawed and centrifuged at
14,000 rpm for 20 min at 4°C. Supernatant was col-
lected, and the pellet was washed with 60% CH3CN and
centrifuged as above. Extracts were combined and lyo-
philized. Dried cell extracts were dissolved in 350 μl
D2O + 30 nmol DSS-d6, and transferred to 5 mm Shi-
gemi NMR tubes.
NMR analysis
NMR spectra were recorded at 18.8 T or 14.1 T on Var-
ian Inova spectrometers. All samples were allowed to
e q u i l i b r a t et o2 0 ° Ci n s i d et h em a g n e tb e f o r ed a t a
acquisition. One-dimensional
1H experiments were
acquired using a standard PRESAT water suppression
sequence with a determined 90° pulse, acquisition time
of 2 s, and recycle delay of 3 s. Cell and media sample
spectra were acquired with 512 and 256 transients,
respectively. Two-dimensional TOCSY, heteronuclear
single quantum coherence (HSQC), and HSQC-TOCSY
NMR experiments were also recorded on selected sam-
ples for spectral assignment. TOCSY spectra were gen-
erated from a standard pulse sequence with a mixing
time of 50 ms, an acquisition time of 341 ms, 56 transi-
ents, and 256 increments. HSQC-TOCSY spectra were
generated with an acquisition time of 150 ms, 40 transi-
ents, and 256 increments. For UDP-GlcNAc identifica-
tion, commercially available nucleotide sugar standards
were prepared in a deuteriated 25 mM K2HPO4 solution
and analyzed by the same set of NMR experiments for
comparison with LN3 cell extracts.
FT-ICR-MS analysis
Following NMR analysis, cell extracts were quantita-
tively transferred from Shigemi tubes to 2 ml microfuge
tubes and lyophilized to remove D2O. Samples were
then redissolved in H2O, diluted to 99% MeOH, and
analyzed via direct infusion nanoelectrospray FT-ICR-
M Si nn e g a t i v ei o nm o d eu s i n gaT h e r m o7 TL T QF T -
ICR-MS, mostly as previously described [5]. The salient
conditions were: Advion Nanomate ‘A’ c h i ps e ta t- 2 . 1
kV with zero PSI head pressure, resulting in a flow rate
of approximately 300 nl/min, and the ICR set to attain a
resolution of 200,000 (at m/z 400, 10% valley definition).
Exact masses were calculated for UDP-GlcNAc and its
isotopologues and assigned using the program PREMISE
(Figure 2) as previously described [5]. In order to deter-
mine percentage
13C enrichment, the intensity of each
isotopologue was measured and normalized to the sum
of all intensities, that is, to provide the mole fraction of
each isotopologue according to Eq. 5:
In,obs =I n,raw/ Ii,raw (5)
The intensities were corrected for the contribution
from natural abundance using the approach previously
described [5].
Metabolite and positional isotopomer analysis
Metabolite concentrations were determined from
1H
NMR peak areas of interest using NUTS software
(Acorn NMR Inc., Livermore, CA, USA) or Varian inte-
gration routines and calibrated against the known con-
centration of internal standard, DSS-d6. For cell
extracts, metabolite concentrations were normalized to
dry cell mass while medium metabolite concentrations
were reported on per ml basis. To correct for
Moseley et al. BMC Biology 2011, 9:37
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using an array of delay times from 0 to 10 s was per-
formed on both medium and cell extracts. Saturation
factors were then calculated and applied to peak areas
based on T1 values in order to determine the true inten-
sity as previously described [8,11].
Positional
13C enrichment for metabolites was deter-
mined by integration of appropriate central and
13C
satellite peaks in one-dimensional and two-dimensional
TOCSY experiments, followed by corrections for differ-
ential relaxation where necessary as previously described
[8,11].
Additional material
Additional file 1: Supplemental figures and table. Figure S1:
metabolite quantification in the medium: consumption and excretion.
Figure S2:
1H-
13C heteronuclear single quantum coherence (HSQC)-total
correlation spectroscopy (TOCSY) of LN3 cells. Table S1: list of models of
13C incorporation into the biochemical units of UDP-N-acetyl-D-
glucosamine (UDP-GlcNAc).
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